|
|
Science Sparks @ ACTREC
|
29th September 2025 |
Vol. No. 14 ; Issue No.702 |
|
Publications
|
1. Janu A, Kulkarni S, Joshi A, K S, Shetty N, Prabhash K, Bhosale S (2025). Incidence and predictors of acute pulmonary embolism in patients with cancer referred for computed tomography pulmonary angiography. International Journal of Cardiovascular Imaging.
2. Banerjee S, Shende SS, Kata L, Lopes RS, Praveen S, Joshi R, Khare NK, Raghuram GV, Shabrish S, Mittra I (2025). Horizontally transferred cell-free chromatin particles function as autonomous 'satellite genomes' and vehicles for transposable elements within host cells. Elife.
|
|
|
Interesting Reads
|
DeMichele A, Clark AS, Shea E, Bayne LJ, Sterner CJ, Rohn K, Dwyer S, Pan TC, Nivar I, Chen Y, Wileyto P, Berry LR, Deluca S, Savage J, Makhlin I, Pant DK, Martin H, Egunsola A, Mears N, Goodspeed BL, Chislock EM, Graves J, Wang J, Shih N, Belka GK, Berry D, Nayak A, Feldman M, Chodosh LA (2025). Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial. Nature Medicine.
|
|
Video of the Week
|
|
WALS: The Joy and Impact of Surgical Research |
|
|
|
|
|
|
Do You Know?
In 1997, FDA approved Rituxan (rituximab), the first monoclonal antibody, to treat non-Hodgkin’s lymphoma.
|
|
|
Cancer News
|
|
Key driver of pancreatic cancer spread identified.
|
MedicalXpress, 24/09/2025
|
New research published in the journal Molecular Cancer reveals that a biological receptor called ALK7 is responsible, by activating two interconnected pathways that work in tandem...
|
|
Patient-derived organoids advance cancer therapy and vaccines.
|
News-Medical, 25/09/2025
|
Organoids are cultivated from patient tumor tissues or stem cells, faithfully reproducing the genetic mutations and microenvironments of the original tumors. Their strength lies in preserving heterogeneity: in colorectal and gastric cancers, organoid drug response testing...
|
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|